COAGULATION AND FIBRINOLYSIS IN THYROID DISEASE

被引:41
作者
RENNIE, JAN
BEWSHER, PD
MURCHISON, LE
OGSTON, D
机构
[1] UNIV ABERDEEN, DEPT MED, ABERDEEN AB9 2ZD, SCOTLAND
[2] UNIV ABERDEEN, DEPT THERAPEUT & CLIN PHARMACOL, ABERDEEN AB9 2ZD, SCOTLAND
关键词
D O I
10.1159/000207759
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:171 / 177
页数:7
相关论文
共 32 条
[1]  
ALKJAERSIG N, 1959, J BIOL CHEM, V234, P832
[2]   MECHANISM OF CLOT DISSOLUTION BY PLASMIN [J].
ALKJAERSIG, N ;
FLETCHER, AP ;
SHERRY, S .
JOURNAL OF CLINICAL INVESTIGATION, 1959, 38 (07) :1086-1095
[3]  
BECHGAARD P, 1946, ACTA MED SCAND, V124, P79
[4]   THYROID AND FIBRINOLYSIS [J].
BENNETT, NB ;
OGSTON, CM ;
MCANDREW, GM .
BRITISH MEDICAL JOURNAL, 1967, 4 (5572) :147-&
[5]  
BIGGS R, 1947, LANCET, V252, P402
[6]   PLASMA NORADRENALINE AND ADRENALIN IN PATIENTS WITH THYROTOXICOSIS AND MYXEDEMA [J].
CHRISTENSEN, NJ .
CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1973, 45 (02) :163-171
[7]   IMMUNOCHEMICAL DISTINCTION BETWEEN ANTIPLASMIN AND ALPHA1-ANTITRYPSIN [J].
COLLEN, D ;
DECOCK, F ;
VERSTRAETE, M .
THROMBOSIS RESEARCH, 1975, 7 (01) :245-249
[8]   CONTRIBUTION OF PLASMA PROTEASE INHIBITORS TO ANTIPLASMIN ACTIVITY IN MAN [J].
CRAWFORD, GPM ;
OGSTON, D ;
DOUGLAS, AS .
CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1976, 51 (02) :215-218
[9]   STUDY OF THE RATE OF PROTEIN SYNTHESIS BEFORE AND DURING THE ADMINISTRATION OF L-TRIIODOTHYRONINE TO PATIENTS WITH MYXEDEMA AND HEALTHY VOLUNTEERS USING N-15 GLYCINE [J].
CRISPELL, KR ;
PARSON, W ;
HOLLIFIELD, G .
JOURNAL OF CLINICAL INVESTIGATION, 1956, 35 (02) :164-169
[10]   SPECIFIC ASSAY OF PROWER-STUART FACTOR AND FACTOR VII [J].
DENSON, KW .
ACTA HAEMATOLOGICA, 1961, 25 (02) :105-&